News
1d
News-Medical.Net on MSNNasal antibody spray shields mice from pollen-triggered allergies and asthmaIntranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...
5d
New Scientist on MSNHay fever relief could come in the form of a nasal 'molecular shield'People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...
A nasal ‘molecular shield’ developed by researchers may soon block mugwort pollen, offering relief from one of the most ...
Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.
4d
News-Medical.Net on MSNMonoclonal antibody delivered through the nose blocks hay fever in miceApproximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...
A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...
Researchers at the Kazakh National Agrarian Research University have developed a pioneering nasal treatment for hay fever ...
A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...
Hosted on MSN3mon
Immune-reactivating antibody therapy shows promise against ... - MSNMore information: Gabriel Osborn et al, Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg ...
Epsilogen’s lead product candidate, MOv18 IgE, is the first therapeutic IgE antibody to enter the clinic and encouraging data from a completed Phase I trial found it to be safe and well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results